Company research
Orthofix Medical Inc.
CIK 884624Updated Nov 15, 2026
OFIX price & chart
Loading TradingView…
NASDAQ:OFIX on TradingView ↗About the company
Orthofix is a global medical technology company dedicated to advancing healing and restoring mobility for patients with complex musculoskeletal conditions. Headquartered in Lewisville, Texas, the Company offers a differentiated portfolio of spinal implants, therapeutic solutions, limb reconstruction systems, biologics and enabling technologies, including the 7D FLASH™ Navigation System. Orthofix’s technology-enabled solutions are designed to support surgeons across the continuum of care and improve outcomes for patients. Learn more at Orthofix.com and follow Orthofix on LinkedIn.
In the news
Recent filings
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
144 filing
4 filing
SCHEDULE 13G/A - filed by ARMISTICE CAPITAL, LLC regarding Orthofix Medical Inc.
Show 5 more recent filings
S-8 filing
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Regulation FD Disclosure
Items 7.01
4 filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 832,610,000Source | 867,872,000Source | 873,020,000Source | 837,157,000Source | 881,998,000Source | 886,601,000Source | 823,144,000Source | 906,050,000Source | 850,647,000Source | 893,294,000Source | 925,315,000Source | 458,629,000Source |
| Property, Plant and Equipment, NetUSD | 130,017,000Source | 146,685,000Source | 130,757,000Source | 129,200,000Source | 154,111,000Source | 125,327,000Source | 130,693,000Source | 158,132,000Source | 129,399,000Source | 139,804,000Source | 159,060,000Source | 58,229,000Source |
| GoodwillUSD | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 71,317,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 75,641,000Source | 104,546,000Source | 65,972,000Source | 78,868,000Source | 108,310,000Source | 69,336,000Source | 81,213,000Source | 112,761,000Source | 72,765,000Source | 98,803,000Source | 117,490,000Source | 47,388,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 62,860,000Source | 30,054,000Source | 103,810,000Source | 65,606,000Source | 26,366,000Source | 120,278,000Source | 57,953,000Source | 26,964,000Source | 82,025,000Source | 83,238,000Source | 33,107,000Source | 50,700,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 130,808,000Source | 124,845,000Source | 135,818,000Source | 129,556,000Source | 125,361,000Source | 137,775,000Source | 131,865,000Source | 125,617,000Source | 135,746,000Source | 134,713,000Source | 128,098,000Source | 82,857,000Source |
| Inventory, NetUSD | 174,042,000Source | 205,812,000Source | 184,475,000Source | 172,993,000Source | 210,040,000Source | 177,818,000Source | 174,480,000Source | 219,076,000Source | 172,319,000Source | 189,452,000Source | 222,166,000Source | 100,150,000Source |
| Assets, CurrentUSD | 394,170,000Source | 386,214,000Source | 446,132,000Source | 395,830,000Source | 386,065,000Source | 461,520,000Source | 390,310,000Source | 398,978,000Source | 416,847,000Source | 433,285,000Source | 420,443,000Source | 255,990,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 23,374,000Source | 23,003,000Source | 21,434,000Source | 24,592,000Source | 21,798,000Source | 25,057,000Source | 23,512,000Source | 24,821,000Source | 23,667,000Source | 23,382,000Source | 32,422,000Source | 22,283,000Source |
| Operating Lease, Right-of-Use AssetUSD | 23,961,000Source | 18,056,000Source | 20,918,000Source | 24,859,000Source | 18,579,000Source | 21,571,000Source | 16,595,000Source | 19,116,000Source | 22,279,000Source | 17,238,000Source | 19,869,000Source | 6,788,000Source |
| Other Assets, NoncurrentUSD | 37,848,000Source | 35,493,000Source | 35,225,000Source | 38,325,000Source | 38,578,000Source | 35,484,000Source | 25,994,000Source | 41,245,000Source | 36,702,000Source | 26,468,000Source | 33,388,000Source | 25,705,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 390,124,000Source | 341,948,000Source | 443,840,000Source | 378,810,000Source | 335,994,000Source | 451,415,000Source | 364,850,000Source | 335,735,000Source | 400,610,000Source | 390,170,000Source | 326,585,000Source | 121,769,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 3,952,000Source | 3,821,000Source | 4,073,000Source | 3,948,000Source | 3,804,000Source | 4,038,000Source | 3,910,000Source | 3,741,000Source | 3,983,000Source | 3,849,000Source | 3,717,000Source | 2,016,000Source |
| Retained Earnings (Accumulated Deficit)USD | -366,111,000Source | -246,995,000Source | -405,039,000Source | -343,316,000Source | -219,607,000Source | -389,241,000Source | -329,235,000Source | -186,164,000Source | -368,333,000Source | -276,141,000Source | -150,144,000Source | 1,251,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 634,000Source | -902,000Source | -277,000Source | 908,000Source | -2,731,000Source | 142,000Source | -2,556,000Source | -660,000Source | 618,000Source | -4,302,000Source | -1,293,000Source | -1,376,000Source |
| Stockholders' Equity Attributable to ParentUSD | 442,486,000Source | 525,924,000Source | 429,180,000Source | 458,347,000Source | 546,004,000Source | 435,186,000Source | 458,294,000Source | 570,315,000Source | 450,037,000Source | 503,124,000Source | 598,730,000Source | 336,860,000Source |
| Additional Paid in Capital, Common StockUSD | 804,011,000Source | 770,000,000Source | 830,423,000Source | 796,807,000Source | 764,538,000Source | 820,247,000Source | 786,175,000Source | 753,398,000Source | 813,769,000Source | 779,718,000Source | 746,450,000Source | 334,969,000Source |
| Liabilities and EquityUSD | 832,610,000Source | 867,872,000Source | 873,020,000Source | 837,157,000Source | 881,998,000Source | 886,601,000Source | 823,144,000Source | 906,050,000Source | 850,647,000Source | 893,294,000Source | 925,315,000Source | 458,629,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 159,847,000Source | 161,898,000Source | 157,010,000Source | 148,381,000Source | 155,967,000Source | 161,033,000Source | 144,116,000Source | 150,621,000Source | 170,482,000Source | 168,628,000Source | 165,223,000Source | 83,624,000Source |
| Operating Lease, Liability, CurrentUSD | 3,155,000Source | 3,931,000Source | 3,061,000Source | 3,048,000Source | 3,733,000Source | 3,108,000Source | 4,205,000Source | 3,534,000Source | 3,147,000Source | 4,023,000Source | 3,477,000Source | 1,638,000Source |
| Accounts Payable, CurrentUSD | 50,459,000Source | 47,060,000Source | 63,531,000Source | 45,098,000Source | 50,362,000Source | 54,686,000Source | 45,176,000Source | 57,147,000Source | 58,392,000Source | 48,803,000Source | 58,357,000Source | 27,598,000Source |
| Operating Lease, Liability, NoncurrentUSD | 26,054,000Source | 15,006,000Source | 24,220,000Source | 26,398,000Source | 15,710,000Source | 24,760,000Source | 13,266,000Source | 16,372,000Source | 25,413,000Source | 14,084,000Source | 17,125,000Source | 5,376,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 6,083,000Source | 5,639,000Source | 4,170,000Source | 1,256,000Source |
| Other Liabilities, NoncurrentUSD | 55,818,000Source | 49,808,000Source | 52,336,000Source | 55,934,000Source | 48,552,000Source | 56,110,000Source | 46,213,000Source | 51,698,000Source | 55,677,000Source | 46,692,000Source | 49,723,000Source | 18,906,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | — | — | — | — | — | — | — | — | 9,857,000Source | 11,391,000Source | 12,189,000Source | 9,611,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 4,207,000Source | 4,097,000Source | 2,089,000Source | 11,297,000Source |
| Long-term Debt, Current MaturitiesUSD | — | 6,250,000Source | — | — | 4,688,000Source | — | — | 3,125,000Source | 0Source | — | 1,250,000Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 157,219,000Source | 112,215,000Source | 221,591,000Source | 157,047,000Source | 113,315,000Source | 221,335,000Source | 156,885,000Source | 115,071,000Source | 157,391,000Source | 157,015,000Source | 93,107,000Source | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 12,941,000Source | 15,173,000Source | 13,273,000Source | 16,871,000Source | 13,493,000Source | 34,431,000Source | 77,321,000Source | 60,061,000Source | 53,063,000Source | 29,019,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 6,533,000Source | 6,469,000Source | 28,688,000Source | 32,455,000Source | 35,707,000Source | 18,443,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 2,964,000Source | -2,379,000Source | 1,583,000Source | 9,526,000Source | 10,411,000Source | 6,735,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 8,845,000Source | -693,000Source | 10,748,000Source | 5,546,000Source | 58,051,000Source | 18,133,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -4,368,000Source | -2,493,000Source | 2,599,000Source | -5,571,000Source | 8,642,000Source | 2,282,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | 93,000Source | 445,000Source | 223,000Source | 1,883,000Source | 579,000Source | 314,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -17,610,000Source | -18,391,000Source | 33,347,000Source | 25,790,000Source | -45,753,000Source | -11,538,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -10,515,000Source | -6,736,000Source | -34,598,000Source | -27,580,000Source | -33,131,000Source | -24,534,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | — | — | — | -146,000Source | — | -28,000Source | 100,000Source | 500,000Source | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | — | — | 60,256,000Source | 21,364,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | — | — | 432,000Source | 5,312,000Source | 4,397,000Source | 1,729,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 63,970,000Source | -651,000Source | -786,000Source | 50,709,000Source | 65,322,000Source | -78,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 35,755,000Source | -25,285,000Source | -623,000Source | 47,981,000Source | -12,943,000Source | -37,147,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 17,300,000Source | 16,900,000Source | 5,800,000Source | 1,400,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 1,583,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 7,181,000Source | 6,531,000Source | 7,735,000Source | 7,824,000Source | 6,533,000Source | 6,469,000Source | 28,688,000Source | 32,455,000Source | 35,707,000Source | 18,443,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 30,000,000Source | 19,000,000Source | 18,900,000Source | 9,400,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 47,300,000Source | 41,100,000Source | 34,200,000Source | 19,600,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | 571,000Source | -1,176,000Source | 746,000Source | -2,751,000Source | 900,000Source | -1,044,000Source | -2,910,000Source | 4,395,000Source | -1,581,000Source | — |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | — | — | — | -331,000Source | -25,000Source | -1,140,000Source | -2,025,000Source | — | — |
| Gain (Loss) on InvestmentsUSD | — | — | -10,000Source | 3,567,000Source | — | -31,000Source | -16,000Source | — | -48,000Source | 5,120,000Source | 1,781,000Source | — |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | 21,548,000Source | 8,335,000Source | 2,185,000Source | 4,029,000Source | 2,916,000Source | 3,042,000Source | -33,788,000Source | -15,770,000Source | -14,453,000Source | — |
| General and Administrative ExpenseUSD | — | — | — | 33,561,000Source | — | — | — | — | — | — | 144,659,000Source | 79,966,000Source |
| GoodwillUSD | — | — | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 194,934,000Source | 71,317,000Source |
| Income Tax Expense (Benefit)USD | — | — | 533,000Source | 751,000Source | 801,000Source | -142,000Source | 74,000Source | 961,000Source | 1,382,000Source | 2,122,000Source | 2,716,000Source | 2,043,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -22,795,000Source | -27,388,000Source | -15,798,000Source | -14,081,000Source | -20,908,000Source | -53,094,000Source | -92,192,000Source | -125,997,000Source | -151,395,000Source | -19,749,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -535,000Source | -2,528,000Source | -778,000Source | 5,730,000Source | -734,000Source | 1,246,000Source | 8,106,000Source | -9,625,000Source | -938,000Source | -3,150,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | 49,000Source | 5,929,000Source | 6,257,000Source | 5,127,000Source | 4,337,000Source |
| Provision for Loan, Lease, and Other LossesUSD | — | — | — | — | — | — | 719,000Source | 1,058,000Source | 2,255,000Source | 1,999,000Source | — | — |
| Operating Expenses | — | — | — | —Source | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 205,634,000Source | 196,606,000Source | 210,933,000Source | 203,121,000Source | 196,708,000Source | 193,646,000Source | 822,312,000Source | 799,491,000Source | 746,641,000Source | 460,713,000Source |
| Cost of RevenueUSD | — | — | 57,111,000Source | 61,553,000Source | 61,226,000Source | 63,588,000Source | 57,162,000Source | 72,027,000Source | 256,295,000Source | 253,606,000Source | 260,368,000Source | 123,544,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 148,102,000Source | 130,137,000Source | 138,030,000Source | 136,493,000Source | 134,911,000Source | 132,981,000Source | 554,329,000Source | 532,525,000Source | — | — |
| Operating Income (Loss)USD | — | — | -17,046,000Source | -18,899,000Source | -8,134,000Source | -16,003,000Source | -14,436,000Source | -48,873,000Source | -81,428,000Source | -84,619,000Source | -139,110,000Source | -13,268,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -535,000Source | -2,528,000Source | -778,000Source | 5,730,000Source | -734,000Source | 1,246,000Source | 8,106,000Source | -9,625,000Source | -938,000Source | -3,150,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -22,262,000Source | -26,637,000Source | -14,997,000Source | -14,223,000Source | -20,834,000Source | -52,133,000Source | -90,810,000Source | -123,875,000Source | -148,679,000Source | -17,706,000Source |
| Income Tax Expense (Benefit)USD | — | — | 533,000Source | 751,000Source | 801,000Source | -142,000Source | 74,000Source | 961,000Source | 1,382,000Source | 2,122,000Source | 2,716,000Source | 2,043,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -22,795,000Source | -27,388,000Source | -15,798,000Source | -14,081,000Source | -20,908,000Source | -53,094,000Source | -92,192,000Source | -125,997,000Source | -151,395,000Source | -19,749,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.57Source | -0.71Source | -0.39Source | -0.36Source | -0.52Source | -1.35Source | -2.33Source | -3.3Source | -4.12Source | -0.98Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.57Source | -0.71Source | -0.39Source | -0.36Source | -0.52Source | -1.35Source | -2.33Source | -3.3Source | -4.12Source | -0.98Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 39,766,000Source | 38,488,000Source | 40,906,000Source | 39,501,000Source | 40,450,000Source | 39,188,000Source | 39,602,345Source | 38,133,684Source | 36,729,258Source | 20,053,548Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 39,766,000Source | 38,488,000Source | 40,906,000Source | 39,501,000Source | 40,450,000Source | 39,188,000Source | 39,602,345Source | 38,133,684Source | 36,729,258Source | 20,053,548Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 30,000,000Source | 19,000,000Source | 18,900,000Source | 9,400,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 1,159,000Source | — | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 12,941,000Source | 15,173,000Source | 13,273,000Source | 16,871,000Source | 13,493,000Source | 34,431,000Source | 77,321,000Source | 60,061,000Source | 53,063,000Source | 29,019,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | 571,000Source | -1,176,000Source | 746,000Source | -2,751,000Source | 900,000Source | -1,044,000Source | -2,910,000Source | 4,395,000Source | -1,581,000Source | — |
| Gain (Loss) on InvestmentsUSD | — | — | -10,000Source | 3,567,000Source | — | -31,000Source | -16,000Source | — | -48,000Source | 5,120,000Source | 1,781,000Source | — |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | 21,548,000Source | 8,335,000Source | 2,185,000Source | 4,029,000Source | 2,916,000Source | 3,042,000Source | -33,788,000Source | -15,770,000Source | -14,453,000Source | — |
| General and Administrative ExpenseUSD | — | — | — | 33,561,000Source | — | — | — | — | — | — | 144,659,000Source | 79,966,000Source |
| Gross ProfitUSD | — | — | 148,523,000Source | 135,053,000Source | 149,707,000Source | 139,533,000Source | 139,546,000Source | 121,619,000Source | 566,017,000Source | 545,885,000Source | 486,273,000Source | 337,169,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -93,273,000Source | -113,197,000Source | -154,794,000Source | -22,318,000Source |
| Interest Income (Expense), NetUSD | — | — | -4,681,000Source | -5,210,000Source | -6,085,000Source | -3,950,000Source | -5,664,000Source | -4,506,000Source | -17,488,000Source | -29,631,000Source | -8,631,000Source | -1,288,000Source |
| Research and Development ExpenseUSD | — | — | 14,774,000Source | 17,294,000Source | 15,944,000Source | 15,934,000Source | 15,320,000Source | 19,766,000Source | 65,847,000Source | 73,643,000Source | 80,231,000Source | 49,065,000Source |
| Selling and Marketing ExpenseUSD | — | — | — | 96,576,000Source | — | — | — | — | — | — | 385,736,000Source | 228,810,000Source |
| Operating Expenses | — | — | — | —Source | — | — | — | — | — | — | — | — |
Filing attachments
ofix-ex99_1.htm · 8-K · 2026-11-09
Exhibit 99.1 News Release Orthofix Reports Third Quarter 2026 Results and Revises Full-Year 2026 Guidance LEWISVILLE, Texas - November 9, 2026 - Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported financial results for the third quarter ended September 30, 2026, and revised its full-year 2026 net sales and non-GAAP adjusted EBITDA guidance. Unless otherwise noted, pro forma results exclude the impact of the discontinued M6™ product lines. Third Qu…
Read attachment ↗ofix-ex99_2.htm · 8-K · 2026-11-09
Drive Profitable Growth Investor Presentation November 2026 2 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, relating to our business and financial outlook, which are based on our current beliefs, assumptions, intentions, plans, expectations, estimates, forecasts and projections. In some cases, you can identify forward…
Read attachment ↗ofix-ex99_1.htm · 8-K · 2026-08-05
EX-99.1 2 ofix-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 News Release Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress LEWISVILLE, Texas - August 5, 2026 - Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both ne…
Read attachment ↗ofix-ex99_2.htm · 8-K · 2026-08-05
EX-99.2 3 ofix-ex99_2.htm EX-99.2 Drive Profitable Growth Investor Presentation August 2026 2 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, relating to our business and financial outlook, which are based on our current beliefs, assumptions, intentions, plans, expectations, estimates, forecasts and projections. In …
Read attachment ↗ofix-ex99_1.htm · 8-K · 2026-05-05
EX-99.1 2 ofix-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 News Release Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance LEWISVILLE, Texas - May 5, 2026 - Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2026, reflecting steady execution following recent spine commercial ch…
Read attachment ↗ofix-ex99_2.htm · 8-K · 2026-05-05
EX-99.2 3 ofix-ex99_2.htm EX-99.2 Drive Profitable Growth Investor Presentation May 2026 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, relating to our business and financial outlook, which are based on our current beliefs, assumptions, intentions, plans, expectations, estimates, forecasts and projections. In some …
Read attachment ↗